Soltis Investment Advisors’s Cingulate CING Stock Holding History
Bought
Maintained
Sold
Other funds holding CING
VCM
KAS
XT
BAM
VFT
QC
HF
Soltis Investment Advisors's CING Position: Q1 2026 in Review
Soltis Investment Advisors increased its Cingulate (CING) stake by 64% in Q1 2026, buying an estimated $41.1K and bringing the position to 16,442 shares worth $102K. The position accounts for 0.01% of the portfolio, ranked #565.
Soltis Investment Advisors first reported a position in CING in Q4 2025 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold CING as of Q1 2026.
- Soltis Investment Advisors held 16,442 shares of Cingulate worth $102K as of Q1 2026.
- Soltis Investment Advisors bought 6,442 Cingulate shares in Q1 2026, an estimated $41.1K.
- Cingulate made up 0.01% of Soltis Investment Advisors's portfolio in Q1 2026, its #565 holding.
- Soltis Investment Advisors first reported a position in Cingulate in Q4 2025 and has held it in 2 quarters since.
- 27 funds tracked by Wall St. Rank held Cingulate as of Q1 2026.
Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.